Literature DB >> 21221097

Patent term extensions for biologic innovators in Japan.

John A Tessensohn1, Shusaku Yamamoto.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21221097     DOI： 10.1038/nbt.1743

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  4 in total

1.  Biosimilars: initial excitement gives way to reality.

Authors:  Mark J Belsey; Laura M Harris; Romita R Das; Joanna Chertkow
Journal:  Nat Rev Drug Discov       Date:  2006-07       Impact factor: 84.694

2.  Shortened life spans of biotech pioneer patents in Japan: a lesson from the DNA chip.

Authors:  Tomomi Aida; Atsuo Konishi; Masatoshi Hagiwara; Kazunori Hashimoto
Journal:  Nat Biotechnol       Date:  2007-05       Impact factor: 54.908

3.  Clinical comparability and European biosimilar regulations.

Authors:  Huub Schellekens; Ellen Moors
Journal:  Nat Biotechnol       Date:  2010-01       Impact factor: 54.908

4.  Accelerated patent examination procedures spur Japanese university innovation.

Authors:  John A Tessensohn; Shusaku Yamamoto
Journal:  Nat Biotechnol       Date:  2009-09       Impact factor: 54.908
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.